Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    OPKO Health Inc.

    NASDAQ: OPK · Real-Time Price · USD
    1.32
    -0.01 (-0.75%)
    At close: Jun 16, 2025, 3:59 PM
    1.34
    1.13%
    Pre-market: Jun 17, 2025, 07:38 AM EDT
    -0.75%
    Bid 1.34
    Market Cap 1.05B
    Revenue (ttm) 689.41M
    Net Income (ttm) -39M
    EPS (ttm) -0.06
    PE Ratio (ttm) -22.08
    Forward PE -6.65
    Analyst Buy
    Ask 1.36
    Volume 2,994,381
    Avg. Volume (20D) 3,371,679
    Open 1.36
    Previous Close 1.33
    Day's Range 1.29 - 1.36
    52-Week Range 1.19 - 2.04
    Beta 1.37

    About OPK

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol OPK
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for OPK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    5 months ago
    +4.14%
    Merck & Compnay and OPKO Health shares are trading... Unlock content with Pro Subscription
    10 months ago
    +11.72%
    OPKO Health shares are trading higher after the company reported better-than-expected Q2 EPS results.
    news image

    4 days ago · zacks.com

    Here's Why You Should Retain OPKO Health Stock in Your Portfolio

    OPK's growth hinges on RAYALDEE and key partnerships, but rising competition and reliance on one drug pose risks.

    news image

    1 month ago · zacks.com

    OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands

    Despite strength in OPKO Health's revenues from the transfer of intellectual property, the company reports an overall soft first-quarter 2025 performance.

    news image

    1 month ago · seekingalpha.com

    OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript

    OPKO Health, Inc. (NASDAQ:OPK ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Yvonne Briggs - Alliance Advisors IR Dr. Phillip Frost - Chairman and CEO Dr. Elias Zerh...

    news image

    1 month ago · zacks.com

    OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say

    The headline numbers for OPKO Health (OPK) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estim...

    news image

    1 month ago · zacks.com

    OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates

    OPKO Health (OPK) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.12 per share a year ago.

    news image

    1 month ago · zacks.com

    Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a Turnaround

    OPKO Health (OPK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimate...

    news image

    3 months ago · reuters.com

    OPKO and Entera partner to develop obesity pill

    OPKO Health and Entera Bio are partnering to develop a once-daily pill for patients with obesity and other disorders, the companies said on Monday.

    Add to Watchlist